Fulcrum Asset Management LLP Bristol Myers Squibb CO Transaction History
Fulcrum Asset Management LLP
- $361 Billion
- Q3 2025
A detailed history of Fulcrum Asset Management LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fulcrum Asset Management LLP holds 11,336 shares of BMY stock, worth $530,638. This represents 0.14% of its overall portfolio holdings.
Number of Shares
11,336
Previous 11,650
2.7%
Holding current value
$530,638
Previous $539 Million
5.2%
% of portfolio
0.14%
Previous 0.15%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,697Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...